Bedoyecta Tri (Hydroxocobalamin, Vitamin B1, Vitamin B6)

Active Ingredient: Hydroxocobalamin, Vitamin B1, Vitamin B6
Dosage:  10000mg/100mg/50mg/2mL
Route of Administration: Intramuscular injection
Dosage Form:  Solution
Quantity per package: 5 Syringed 2 ml
Availability: Out of stock

Why Is Bedoyecta Tri Not Used in the USA?

In the United States, Bedoyecta Tri is less common primarily due to the availability of a wide range of oral vitamin supplements that are rigorously regulated and widely accepted. The U.S. also has stringent regulations regarding injectable products, requiring them to be prescribed by a healthcare provider and administered under medical supervision. Moreover, the general population in the U.S. has better access to a varied diet that often makes specific vitamin injections unnecessary for the majority.

Drugs Sold in the USA for Similar Purposes

While the exact combination of Bedoyecta Tri might not be available, there are similar preparations used in the United States for the prevention and treatment of vitamin deficiency:

What is Bedoyecta Tri?

Bedoyecta Tri is a multivitamin supplement that contains Hydroxocobalamin (a form of vitamin B12), Vitamin B1 (Thiamine), Vitamin B6 (Pyridoxine). The released form is an injectable solution. It is used to prevent vitamin deficiency and give them a metabolism enhancement.

Indications

Bedoyecta Tri is indicated in the prevention and treatment of vitamin deficiency of the formula. It is useful in the treatment of neuritis and polyneuritis of nutritional, diabetic, alcoholic and toxic origin due to the use of drugs. It can also be used in alcoholic beriberi, Wernicke’s encephalopathy, neuralgia and peripheral neuropathies, sciatica, facial paralysis, postherpetic neuralgia and in some metabolic disorders such as diabetic acidosis. The product covers the increase in vitamin B complex requirements demanded by situations that occur with increased energy use. It is used in the therapy of megaloblastic anemia due to vitamin B12 deficiency.

Where is Bedoyecta Tri Used?

Bedoyecta Tri is popular in countries with widespread nutritional deficiencies, particularly where diets may lack sufficient amounts of B vitamins. It is notably used in:

• Latin America: Countries like Mexico are prominent users of Bedoyecta Tri. The popularity here can be attributed to cultural dietary patterns and possibly lower intake of certain nutrients through food. Marketing and local manufacturing also boost its visibility and availability.
• Southeast Asia: Some regions may use similar formulations due to similar reasons—dietary gaps and the need for affordable healthcare solutions.
• Africa: Nutritional supplements like Bedoyecta Tri may be used to combat malnutrition-related deficiencies in B vitamins.

In these regions, the use of Bedoyecta Tri helps address gaps in nutrient intake that are not met by the local diet. The direct administration of vitamins via injection can be particularly useful in populations where gastrointestinal absorption might be compromised, or where oral supplementation compliance is low.

Dosage and administration

For intramuscular administration. The average dose is one to two syringes per week or according to medical indications, depending on the severity of the case.

Contraindications

• Hypersensitivity to the components of the formula;
• Polycythemia vera;
• Pregnancy, breastfeeding, and newborns;

Side effects

The administration of Bedoyecta Tri can produce reactions such as skin rash, nausea, vomiting and, sometimes, anaphylactic shock in susceptible people.

Overdose

Given the water-soluble characteristics of vitamins and that there is no accumulation site in the body, the overdose of B vitamins would be rapidly eliminated by the kidneys and/or body secretions. In case of type I hypersensitivity reactions, its use should be discontinued immediately.

Interaction

Pyridoxine (Vitamin B6) can interact with digoxin or potassium-sparing diuretics. The dose of Vitamin B6 may be insufficient in patients who are taking isoniazid, penicillin, cycloserine, hydralazine. Metformin decreases the bioavailability of B12 and furosemide causes loss of complex B (mainly B1 and folic acid), so it is advisable to increase the dose. Vitamin B6 decreases the effectiveness of levodopa since it increases its metabolism.